Company intelligence
Aera Therapeutics
Enabling the next generation of transformative genetic medicines
Biotechnology Research
Cambridge, US
93 employees
1 public signals
About Aera Therapeutics
Aera’s mission is to unlock the potential of genetic medicines by tacking the greatest unmet need in the field today – delivery. Aera has multiple proprietary delivery platforms including targeted lipid nanoparticles (tLNPs), antibody oligonucleotide conjugates (AOCs), and protein nanoparticles (PNPs), that are being developed to enable next-generation genetic medicines across a range of therapeutic modalities and disease areas. These platforms have the potential to overcome the limitations of today’s delivery technologies and expand the application of genetic medicines.
Verified activity
Signals from Aera Therapeutics
1 published signal